"Heterozygote" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An individual having different alleles at one or more loci regarding a specific character.
Descriptor ID |
D006579
|
MeSH Number(s) |
G05.380.383
|
Concept/Terms |
Genetic Carriers- Genetic Carriers
- Carrier, Genetic
- Genetic Carrier
- Carriers, Genetic
|
Below are MeSH descriptors whose meaning is more general than "Heterozygote".
Below are MeSH descriptors whose meaning is more specific than "Heterozygote".
This graph shows the total number of publications written about "Heterozygote" by people in this website by year, and whether "Heterozygote" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 2 | 2 |
1996 | 1 | 6 | 7 |
1997 | 0 | 3 | 3 |
1998 | 2 | 5 | 7 |
1999 | 2 | 3 | 5 |
2000 | 0 | 4 | 4 |
2001 | 0 | 9 | 9 |
2002 | 0 | 13 | 13 |
2003 | 1 | 9 | 10 |
2004 | 0 | 8 | 8 |
2005 | 1 | 6 | 7 |
2006 | 0 | 7 | 7 |
2007 | 0 | 6 | 6 |
2008 | 1 | 4 | 5 |
2009 | 0 | 4 | 4 |
2010 | 0 | 5 | 5 |
2011 | 7 | 10 | 17 |
2012 | 1 | 9 | 10 |
2013 | 1 | 12 | 13 |
2014 | 3 | 9 | 12 |
2015 | 2 | 13 | 15 |
2016 | 1 | 12 | 13 |
2017 | 0 | 12 | 12 |
2018 | 1 | 18 | 19 |
2019 | 1 | 5 | 6 |
2020 | 1 | 11 | 12 |
2021 | 3 | 4 | 7 |
2022 | 0 | 5 | 5 |
2023 | 0 | 4 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Heterozygote" by people in Profiles.
-
Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival. Cancer Med. 2023 08; 12(15):16142-16162.
-
Insulin Deficiency From Insulin Gene Mutation Leads to Smaller Pancreas. Diabetes Care. 2023 04 01; 46(4):773-776.
-
Contralateral Breast Cancer Risk Among Carriers of Germline Pathogenic Variants in ATM, BRCA1, BRCA2, CHEK2, and PALB2. J Clin Oncol. 2023 03 20; 41(9):1703-1713.
-
Refining Risk for Alzheimer's Disease Among Heterozygous APOE?4 Carriers. J Alzheimers Dis. 2023; 94(2):483-489.
-
Significance of hereditary gene alterations for the pathogenesis of adult bone marrow failure versus myeloid neoplasia. Leukemia. 2022 12; 36(12):2827-2834.
-
Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers. Commun Biol. 2022 10 06; 5(1):1061.
-
Heterozygote Advantage of the Type II Deiodinase Thr92Ala Polymorphism on Intrahospital Mortality of COVID-19. J Clin Endocrinol Metab. 2022 05 17; 107(6):e2488-e2501.
-
Expanding ACTA2 genotypes with corresponding phenotypes overlapping with smooth muscle dysfunction syndrome. Am J Med Genet A. 2022 08; 188(8):2389-2396.
-
Broadening our Understanding of the Immune Landscape in Lynch Syndrome. Gastroenterology. 2022 04; 162(4):1024-1025.
-
De novo coding variants in the AGO1 gene cause a neurodevelopmental disorder with intellectual disability. J Med Genet. 2022 Oct; 59(10):965-975.